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Hybrid Hydroxyapatite Nanoparticle Colloidal Gels
are Injectable Fillers for Bone Tissue Engineering
Qun Wang, PhD,1,2 Zhen Gu, PhD,3 Syed Jamal, MS,4
Michael S. Detamore, PhD,4 and Cory Berkland, PhD4,5
Injectable bone fillers have emerged as an alternative to the invasive surgery often required to treat bone defects.
Current bone fillers may benefit from improvements in dynamic properties such as shear thinning during injection
and recovery of material stiffness after placement. Negatively charged inorganic hydroxyapatite (HAp) nano-
particles (NPs) were assembled with positively charged organic poly(d,l-lactic-co-glycolic acid) (PLGA) NPs to
create a cohesive colloidal gel. This material is held together by electrostatic forces that may be disrupted by shear to
facilitate extrusion, molding, or injection. Scanning electron micrographs of the dried colloidal gels showed a well-
organized, three-dimensional porous structure. Rheology tests revealed that certain colloidal gels could recover after
being sheared. Human umbilical cord mesenchymal stem cells were also highly viable when seeded on the colloidal
gels. HAp/PLGA NP colloidal gels offer an attractive scheme for injectable filling and regeneration of bone tissue.
Introduction
In the United States, bone injury occurs to seven millionpeople every year and treatments cost upward of $215 bil-
lion annually.1,2 Repair of skeletal defects resulting from trau-
matic insult, tumor ablation, or congenital deformities remains
a formidable challenge for surgeons.3 Clinically, injectable fill-
ers are attractive alternatives to surgical operations since it can
reduce scar formation, infection, patient discomfort, and treat-
ment cost.4 Particularly, injectable scaffolds injected at low
viscosity may be ideal tissue engineering scaffolds for bone
repair or for delivery of cells to injured sites. This approach is
minimally invasive and is capable of filling complex three-
dimensional (3D) defects. The desirable injectable tissue fillers
should have modest viscosity upon application and solidify or
transition to high viscosity upon settlement. Normally, inject-
able tissue fillers are chemically crosslinked to polymerize the
material. Unfortunately, toxic chemicals are often applied in
this process. These agents may negatively affect the scaffolds,
destabilize loaded biomolecules, and pose toxicity concerns.
Colloidal gels with 3D microporous structures composed of
nanomaterials were manufactured to overcome these draw-
backs.5–7 These systems comprised oppositely charged nano-
particles (NPs) with high solid contents solidifying the material
through interparticle interactions.8,9 Owing to short range and
temporary electrostatic forces and van der Waals attraction,
colloidal gels with unique pseudoplastic behavior facilitated
the formation of shape-specific injectable tissue fillers with po-
rous microstructures.10,11 Recent research has leveraged similar
advantages to achieve special bulk materials for various appli-
cations,12–17 including colloidal gels aimed toward regenerating
tissues.18,19 The unique properties of high-concentration, cohe-
sive colloidal gels make it a potential candidate as an injectable
filler to repair bone, such as craniofacial defects.
Hydroxyapatite (HAp) NPs represent an attractive build-
ing block for colloidal gels. HAp is a native mineral compo-
nent of bone that has already been approved by the Food and
Drug Administration for craniofacial repairs.3,20–22 This os-
teogenic and bioresorbable material can interact with neigh-
boring bone and can be replaced by new bone.23,24 Moreover,
HAp has been found to be an effective substrate for cell at-
tachment and expression of osteoblast phenotypes.25,26
Colloidal gels must also be compatible with native tissue
and/or with progenitor cells that can further stimulate re-
generation of tissue. Human mesenchymal stem cells can
differentiate into adipocytes, chondrocytes, neurons, fibro-
blasts, myoblasts, and osteoblasts.27–31 Compared to human
bone marrow mesenchymal stem cells, human umbilical cord
mesenchymal stem cells (hUCMSCs) may be advantageous
because of ready availability, noninvasive acquisition, and
minimal ethical issues. hUCMSCs also exhibit desirable plas-
ticity and developmental flexibility.27 Furthermore, hUCMSCs
appear to minimize or eliminate rejection by the immune
system as compared to other cell sources.27
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The aim of this work was to create colloidal gels from nat-
ural materials and to evaluate compatibility with hUCMSCs.
Here, negatively charged HAp NPs were combined with pos-
itively charged poly(d,l-lactic-co-glycolic acid) (PLGA) NPs to
form an injectable colloidal gel bone tissue filler. PLGA NPs
were surface-modified chitosan, a naturally occurring poly-
saccharide that has been widely used in tissue scaffolds.32–35
Injectable bone fillers were created by mixing the negatively
charged HAp NPs and positively charged PLGA NPs in ratios.
At certain compositions, colloidal gels exhibited a yield point
indicative of Bingham plastic behavior, but were also shear
thinning. The negligible cytotoxicity to hUCMSCs and desir-
able rheological behavior supported potential translation of
these materials for bone tissue engineering.
Materials and Methods
Materials
All materials were purchased from Fisher Scientific, Inc.
unless otherwise stated. PLGA (75:25) (7525 DLG 2.5E) was
obtained from Lakeshore Biomaterials. Chitosan with a de-
gree of deacetylation at 75%–85% and Mn at 612 kDa were
purchased from Sigma-Aldrich Co.
Preparation of negatively charged HAp NPs
Negatively charged HAp NPs were prepared by precipi-
tation of calcium chloride and sodium phosphate in an al-
kaline medium, according to the reaction:
5CaCl2  2H2Oþ 3Na2HPO4  7H2Oþ 4OH
¼Ca5(PO4)3(OH)þ 6NaClþ 34H2Oþ 4Cl
A ten milliliter CaCl2$2H2O solution with a concentration
0.1M was added into a 100mL Na2HPO4$7H2O solution with
a concentration 0.006M through a pump at 30mL/h under
stirring at 200 rpm. The pH of the suspension was adjusted to
10 by adding the NaOH solution with a concentration 2M.
Poly (acrylic acid) (PAA) was used as a crystal growth in-
hibitor at a constant concentration 50ppm. NPs were washed
and collected by a high-speed centrifuge (Avanti 30; Beckman
Co.) (14,000 rpm, 15min). A fine powder of NPs available for
usage was obtained by lyophilization.
Preparation of positively charged PLGA NPs
Positively charged PLGA NPs were fabricated through a
solvent diffusion method. One hundred milligrams of PLGA
was dissolved in 10mL of acetone followed by addition into a
0.2% chitosan solution. Stirring remained overnight to evap-
orate excess acetone. NPs were washed and collected by high-
speed centrifuge to remove excess chitosan. A fine powder of
NPs available for usage was obtained by lyophilization.
Preparation of colloidal gels
Lyophilized NPs (HAp or PLGA) were dispersed in
deionized water at the reported concentrations and ratios.
Homogeneous mixtures were obtained in a bath sonicator for
3min and stored at 4C for 2 h allowing structural organi-
zation before use. Colloidal gels with different ratios of HAp
NPs and PLGA NPs were designated as H100, HP73, HP55,
HP37, and P100 (H: HAp NPs; P: PLGA NPs; the weight
ratios of HAp NPs to PLGA NPs were 100:0, 70:30, 50:50,
30:70, and 0:100, respectively).
Characterization of NPs and colloidal gels
Sizes and zeta potentials of the HAp and PLGA NPs were
measured by the ZetaPALS dynamic light scattering instru-
ment (ZetaPALS; Brookhaven). All samples were tested in
triplicate. The Fourier Transform Infrared Spectroscopy
(FTIR) spectra of different NPs and colloidal gels were
obtained using an FTIR spectrometer (Prota Type; ABB
Bomem) after mixing with KBr pellets. The X-ray diffraction
patterns of different NPs and colloidal gels were determined
using a Shimadzu Lab-XRD-6000·diffractometer, with
nickel-filtered CuKa radiation at 40 kV and 50 mA in the 2h
range of 5 - 45.
Scanning electron microscopy (SEM) was performed by the
Jeol JSM-6380 field emission scanning electron microscope at
the accelerating voltage of 10kV. Briefly, the colloidal gels
were suspended in distilled water and subsequently evapo-
rated in droplets onto the carbon tape of the SEM stub.
Thereafter, gold coating was performed and samples were
stored for future use. Atomic force microscopy (AFM) images
were obtained at ambient conditions using a Multimode Na-
noscope E Atomic Force Microscope (Veeco Instruments) op-
erating in a contact mode. Samples were prepared via
evaporation of colloidal gel suspension on a glass cover slip at
room temperature followed by spin coating. Dry samples were
scanned by Veeco silicon nitride tips with a force constant of
0.12N/m at 2Hz with a set point of *1–2 V for all images.
Rheological experiments
Rheological experiments were performed on the con-
trolled stress rheometer (AR2000; TA Instrument, Ltd.). A 2
cone steel plate (20mm diameter) was used and the 500-mm
gap was filled with a colloidal gel. A solvent trap filled with
distilled water was used to prevent evaporation of water.
The viscosity (g) was monitored and the recoverability was
assessed at specific time breaks between cycles. All experi-
ments were performed in triplicate.
Cytotoxicity
hUCMSCs were isolated and cultured as previously de-
scribed.36 Before cell seeding, the colloidal gels were sterilized
under UV light for 20min. Cells were deposited on colloidal
gels in each well of 12-well polystyrene culture plates with cell
density of 1· 104 cells/well. Then, 2mL of culture medium
was added into wells. Cells were cultured in a monolayer onto
the gel surface for 2 weeks, with half of the media changed
every other day. Cells cultured in blank polystyrene tissue
culture plates were used as control. Subsequently, LIVE/
DEAD assay was performed on the cells before being sub-
jected to fluorescence microscopy (Nikon TS100).
Results and Discussion
Characterizations of NPs and hybrid colloidal gels
Figure 1 illustrated the fabrication of hybrid HAp/PLGA
NP colloidal gels. In details, negatively charged HAp NPs
were prepared by precipitation of calcium chloride and so-
dium phosphate in an alkaline medium. The formation of
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positive charged PLGA NPs occurred in the chitosan poly-
electrolyte solution, resulting in a surface coating of posi-
tively charged polymers. The properties of each particle type
are shown in Table 1. Zeta potential and particle size are two
critical factors influencing the cohesive properties of colloidal
gel systems.15 The particle size of PLGA NPs was 10 times as
that of HAp NPs and the absolute value of the particle zeta
potential of PLGA NPs was much larger compared with
HAp NPs. These differences influenced gel properties and
made it possible to employ PLGA NPs to improve the in-
jectability of HAp bioceramic scaffolds.
As mentioned before, colloidal gels comprised oppositely
charged NPs may stiffen through physical interparticle inter-
actions. This phenomenon can facilitate the fabrication of
shape-specific materials with 3D porous structures and avoid
chemical crosslinking agents normally required during solidi-
fication. Figure 2 showed the FTIR spectra and X-ray diffraction
patterns of pure HAp NPs, pure PLGA NPs, and hybrid col-
loidal gel HP55, respectively. In Figure 2A, there were no new
characteristic absorption bands in the blended colloidal gel.
Figure 2B also showed no new peaks in the blended colloidal
gel HP55. All the results gave strong evidence that the hybrid
colloidal gels were simply a physically crosslinked system
without chemical intermolecular interactions. Interestingly, due
to the amorphous structure of PLGA, the absorbance in the
X-ray diffraction pattern was much lower compared with HAp.
And the peaks of PLGA were eventually smoothed and further
disappeared in the X-ray pattern of hybrid materials.
Morphology and shape retention of hybrid
colloidal gels
Oppositely charged NPs were first suspended separately
in deionized water at 20% (w/w). The very small size of
HAp NPs yielded a densely packed material when dried as
compared to PLGA NPs (Fig. 3A, B). Mixing these two op-
positely charged NPs yielded colloidal gels with differences
in the internal structures as observed by SEM and AFM (Fig.
3). As the relative amount of PLGA NPs increased (Fig. 3C:
HP73; 3D: HP55; 3E: HP37), colloidal gels exhibited a more
open porous structure. The oppositely charged NPs assem-
bled into small micrometer-scale agglomerates, which con-
nected at larger scales to organize the porous bulk material.
AFM micrographs of the HP55 colloidal gel (Fig. 3F) also
exhibited the porous bulk structure typical of colloidal gels.
Colloidal systems comprised oppositely charged NPs ex-
hibiting special pseudoplastic behaviors facilitating the for-
mation of materials with a desired shape. Here, the
pseudoplastic property of the colloidal system has been lev-
eraged to construct injectable scaffolds for bone tissue engi-
neering (Fig. 4). Figure 4A–C shows exemplary molded
scaffolds of colloidal gels HP37, HP55, and HP73, respectively.
The results demonstrated that gels with different composi-
tions showed different moldability resulting from the chang-
ing ratios of oppositely charged NPs. Different colloidal gels
(Fig. 4D-A indicated as HP37; D-B indicated as HP55; and D-C
indicated as HP73) were put into 50-mL Falcon tubes to study
FIG. 1. Schematic representation of the process for fabrication of oppositely charged HAp and PLGA NPs and formation of
the colloidal gel. HAp, hydroxyapatite; PLGA, poly(d,l-lactic-co-glycolic acid). Color images available online at www
.liebertpub.com/tea
Table 1. PLGA and HAp NP Properties
PLGA HAp
Size (nm) 218– 24 20– 1
Polydispersity 0.132 0.072
Zeta potential (mV) + 21.1 – 1.8 - 12.2 – 1.0
HAp, hydroxyapatite. PLGA, poly(d,l-lactic-co-glycolic acid);
NPs, nanoparticles.
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FIG. 2. Fourier Transform Infrared Spectroscopy spectra (A) and X-ray (B) diffraction patterns of pure HAp NPs (HA), pure
PLGA NPs (PLGA), and hybrid HP55 colloidal gel (HA-PLGA).
FIG. 3. Scanning electron microscopy pictures of pure HAp NPs (A, B), and colloidal gels HP37 (C), HP55 (D), and HP73
(E). An atomic force microscopy picture of the colloidal gel HP55 (F) [scale bars were 100 nm for (A) and 1mm for (B–E). The
unit of (F) was nm]. Color images available online at www.liebertpub.com/tea
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shape retention. Systems composed of an overall equal charge
balance (HP55 with 1:1 mass ratio, Fig. 4D-B) demonstrated
less fluidity and retained their structure. This confirmed the
key roll of the overall charge ratio to the structures and co-
hesive properties of the colloidal gels.
Shear thinning and recoverability of hybrid
colloidal gels
Rheological studies were performed on different colloidal
gels. A strong dependence of viscosity on different NP mass
ratios (Fig. 5A) and NP concentrations (Fig. 5B) was ob-
served. At the same NP concentration (20%), pure HAp NPs
yielded the highest viscosity gel, presumably due to the tight
structure and minimal porosity (Fig. 5A). Pure HAp NPs
showed limited reversibility, however, during the forward-
and-backward stress sweep experiments. This confirmed the
poor cohesiveness of calcium phosphate ceramic paste,
which may point to a substantial limitation of this material as
a tissue engineering scaffold.
As expected, the addition of PLGA NPs to HAp NPs
significantly improved cohesiveness of this material as evi-
denced by retention of viscosity after shear (Fig. 5A). Com-
pared to other ratios, gels with more negatively charged NPs
FIG. 4. Shaped tissue scaf-
folds made by colloidal gels
HP37 (A), HP55 (B), HP73
(C), and shape stability tests
(D [A, B, C]). Color images
available online at www
.liebertpub.com/tea
FIG. 5. Viscosity and shear thinning behavior of colloidal gels (20% concentration) mixed at different NP mass ratios (A)
and HP55 colloidal gel at different concentrations (B) for accelerating (solid symbols) and decelerating (open symbols) the
shear rate.
2590 WANG ET AL.
(HP73, 7:3 mass ratio of HAp to PLGA NPs, 20% concen-
tration) yielded higher viscosity. On the contrary, gels with
excess positive charged NPs (HP37, 3:7 mass ratio of HAp to
PLGA NPs, 20% concentration) showed more fluidity. The
5:5 mass ratio recovered the original viscosity that was ob-
served before shearing the material. The balance of positively
charged and negatively charged NPs yielded a highly co-
hesive network that recovered quickly. Pure PLGA NP gels
showed minimal shear thinning behavior (P100).
As the concentration of NPs was increased, higher viscosity
and more shear thinning behavior were observed in the col-
loidal system (Fig. 5B). The HP55 colloidal gel at 20% con-
centration showed excellent recovery of the initial material
viscosity. At 30% concentration, this same ratio yielded col-
loidal gels that did not recover viscosity to the same extent.
This dynamic property may hinge upon a fine balance be-
tween particle concentration as well as the mass ratio of op-
positely charged particles. For example, particle mobility may
be hindered at higher concentrations, thus impeding restora-
tion of interparticle interactions and slowing material recovery.
As colloidal systems, the cohesive strength depends upon
interparticle interactions.5 These electrostatic forces and van
der Waals attractions were determined by the NP concen-
tration and mass ratios of oppositely charged particles within
the colloidal systems. Negatively charged HAp and posi-
tively charged PLGA NPs self-assembled through interpar-
ticle interactions to form a stable 3D porous structure. In
static status, colloidal assemblies with a stable structure ex-
hibit high viscosity at equilibrium (Fig. 4). Once the static
status is disrupted, the gel system will exhibit pseudoplastic
properties. If the external force is removed, the cohesion of
the colloidal gel will be recovered and the 3D porous struc-
ture will be reconstructed. This unique recoverability makes
the colloidal gel an excellent injectable material for applica-
tions in tissue engineering. All the results suggested that the
hybrid HAp/PLGA NP colloidal gels were excellent inject-
able materials for bone regeneration applications, such as
filling of irregular bone defects.
Negligible cytotoxicity of hybrid colloidal gels
to hUCMSCs
Stem cells have the great potential to revolutionize tradi-
tional medicine with the ability to repair the diseased or
damaged tissues. Preformed tissue scaffolds have many
drawbacks, including in some cases, poor biocompatibility to
the cells, difficulties in seeding cells, and complications with
cell/material placement or retention during minimally inva-
sive surgeries.37,38 HAp/PLGA NP colloidal gels were tested
to determine cell viability, since the viscoelastic properties of
these materials are conducive to placement via injection.
hUCMSCs were isolated and cultured on HP73, HP55, or
HP37 gels for up to 2 weeks. Cells treated without colloidal
gels on blank polystyrene tissue culture plates were used as a
control. Afterward, LIVE/DEAD viability assays were con-
ducted to the scaffolds with cells. In these experiments,
negligible cell death was observed in cell-loaded hybrid
colloidal gels for 48 h and for 2 weeks (Fig. 6). This qualita-
tive result demonstrated that hybrid HAp/PLGA NP col-
loidal gels possessed negligible cytotoxicity to hUCMSCs.
Hence, resulted colloidal gels are potentially safe scaffolds
for seeding stem cells. The high porosity and elasticity of the
colloidal gels may contribute to this application.
Conclusions
In this article, a new colloidal gel system composed of
negatively charged inorganic HAp NPs and positively
charged organic PLGA NPs was demonstrated. The cohesive
FIG. 6. Human umbilical
cord mesenchymal stem cells
cultured on colloidal gels HP
73 (B), HP55 (C), and HP37
(D) demonstrated high via-
bility comparing to reference
(A) treated without colloidal
gels (scale bars were 1mm).
Color images available online
at www.liebertpub.com/tea
A FUNCTIONAL INJECTABLE FILLER FOR BONE TISSUE ENGINEERING 2591
strength of the gels derived from the interparticle interac-
tions, such as electrostatic forces and van der Waals attrac-
tion. The unique response to external shear force and
recoverable properties make this colloidal gel system an ex-
cellent candidate for injectable bone filling. Cytotoxicity tests
also demonstrated negligible toxicity to hUCMSCs. In future
research, stability tests will be carried out to investigate the
effects of pH and ionic strength on the gels’ properties. The
integration of drug release strategies (e.g., small molecules
and growth factors) will further explore for advanced ap-
plications for bone tissue engineering combined with local
controlled drug release.
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